Cargando…
Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
Despite great improvements in the diagnosis and treatment of neoplasms, metastatic disease is still the leading cause of death in cancer patients, with mortality rates still rising. Given this background, new ways to treat cancer will be important for development of improved cancer control strategie...
Autores principales: | Xiao, Xing-Hua, Lv, Lin-Chen, Duan, Jing, Wu, Ye-Meng, He, Shu-Jin, Hu, Zhen-Zhen, Xiong, Li-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017947/ https://www.ncbi.nlm.nih.gov/pubmed/29596304 http://dx.doi.org/10.3390/molecules23040787 |
Ejemplares similares
-
Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
por: Duan, Xin, et al.
Publicado: (2021) -
Cdc42: A Novel Regulator of Insulin Secretion and Diabetes-Associated Diseases
por: Huang, Qi-Yuan, et al.
Publicado: (2019) -
MicroRNA-224 Suppresses Colorectal Cancer Cell Migration by Targeting Cdc42
por: Ke, Tao-Wei, et al.
Publicado: (2014) -
MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
por: Gu, Gengshi, et al.
Publicado: (2018) -
Activation of Cdc42 by trans interactions of the cell adhesion molecules nectins through c-Src and Cdc42-GEF FRG
por: Fukuhara, Tatsuro, et al.
Publicado: (2004)